Affiliation:
1. Department of Mathematics The Hong Kong University of Science and Technology Hong Kong People's Republic of China
Abstract
AbstractWhen multiple candidate subgroups are considered in clinical trials, we often need to make statistical inference on the subgroups simultaneously. Classical multiple testing procedures might not lead to an interpretable and efficient inference on the subgroups as they often fail to take subgroup size and subgroup effect relationship into account. In this paper, built on the selective traversed accumulation rules (STAR), we propose a data‐adaptive and interactive multiple testing procedure for subgroups which can take subgroup size and subgroup effect relationship into account under prespecified tree structure. The proposed method is easy‐to‐implement and can lead to a more interpretable and efficient inference on prespecified tree‐structured subgroups. Possible accommodations to post hoc identified tree‐structure subgroups are also discussed in the paper. We demonstrate the merit of our proposed method by re‐analyzing the panitumumab trial with the proposed method.
Subject
Statistics and Probability,Epidemiology
Reference48 articles.
1. Inference on Selected Subgroups in Clinical Trials
2. Adaptive Designs for Confirmatory Clinical Trials with Subgroup Selection
3. Food & Drug Administration.FDA approves atezolizumab for first‐line treatment of metastatic NSCLC with high PD‐L1 expression.2021https://www.fda.gov/drugs/resources‐information‐approved‐drugs/fda‐approves‐atezolizumab‐first‐line‐treatment‐metastatic‐nsclc‐high‐pd‐l1‐expression
4. Identification and inference for subgroups with differential treatment efficacy from randomized controlled trials with survival outcomes through multiple testing
5. Teoria statistica delle classi e calcolo delle probabilita;Bonferroni C;Pubblicazioni del R Istituto Superiore di Scienze Economiche e Commericiali di Firenze,1936
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献